These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15659058)

  • 21. Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
    Hassel D; Scholz EP; Trano N; Friedrich O; Just S; Meder B; Weiss DL; Zitron E; Marquart S; Vogel B; Karle CA; Seemann G; Fishman MC; Katus HA; Rottbauer W
    Circulation; 2008 Feb; 117(7):866-75. PubMed ID: 18250272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?
    Hofman N; Tan HL; Alders M; van Langen IM; Wilde AA
    J Am Coll Cardiol; 2010 Jun; 55(23):2570-6. PubMed ID: 20513597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ion channelopathies: what have they taught us about arrhythmias and anti-arrythmic therapy.
    Subbiah RN; Campbell TJ; Vandenberg JI
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):595. PubMed ID: 16026521
    [No Abstract]   [Full Text] [Related]  

  • 24. hERG1 channel activators: a new anti-arrhythmic principle.
    Grunnet M; Hansen RS; Olesen SP
    Prog Biophys Mol Biol; 2008; 98(2-3):347-62. PubMed ID: 19351523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden cardiac death and inherited arrhythmia syndromes.
    Sarkozy A; Brugada P
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S8-20. PubMed ID: 16138889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic mutations and arrhythmia: simulation from DNA to electrocardiogram.
    Zhu ZI; Clancy CE
    J Electrocardiol; 2007; 40(6 Suppl):S47-50. PubMed ID: 17993328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics.
    Chiamvimonvat N; Chen-Izu Y; Clancy CE; Deschenes I; Dobrev D; Heijman J; Izu L; Qu Z; Ripplinger CM; Vandenberg JI; Weiss JN; Koren G; Banyasz T; Grandi E; Sanguinetti MC; Bers DM; Nerbonne JM
    J Physiol; 2017 Apr; 595(7):2229-2252. PubMed ID: 27808412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.
    Casini S; Verkerk AO; Remme CA
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):325-344. PubMed ID: 28721524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ryanodine receptor-targeted anti-arrhythmic therapy.
    Wehrens XH; Lehnart SE; Marks AR
    Ann N Y Acad Sci; 2005 Jun; 1047():366-75. PubMed ID: 16093511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late sodium current inhibition in acquired and inherited ventricular (dys)function and arrhythmias.
    Remme CA; Wilde AA
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):91-101. PubMed ID: 23292167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Short QT syndrome as an inherited condition].
    Møller DV; Hedley PL; Olesen M; Kanters J; Svendsen JH; Christiansen M
    Ugeskr Laeger; 2011 Feb; 173(6):420-4. PubMed ID: 21299935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Control of Potassium Channels.
    Amin AS; Wilde AA
    Card Electrophysiol Clin; 2016 Jun; 8(2):285-306. PubMed ID: 27261822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex and gender aspects in antiarrhythmic therapy.
    Kurokawa J; Kodama M; Furukawa T; Clancy CE
    Handb Exp Pharmacol; 2012; (214):237-63. PubMed ID: 23027454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
    Vos MA; Crijns HJ
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):27-34. PubMed ID: 12122969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it time to include ion channel diseases among cardiomyopathies?
    Corrado D; Basso C; Thiene G
    J Electrocardiol; 2005 Oct; 38(4 Suppl):81-7. PubMed ID: 16226080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological targeting in inherited arrhythmia syndromes.
    Zumhagen S; Strutz-Seebohm N; Seebohm G; Schulze-Bahr E
    Curr Med Chem; 2014; 21(11):1308-19. PubMed ID: 24251569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The research practice of anti-arrhythmic agents targeting on potassium ion channel].
    Yang Q; Wang XJ; Tang YQ; You QD
    Yao Xue Xue Bao; 2011 Jan; 46(1):12-8. PubMed ID: 21465803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
    Billman GE
    Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.